Skip to content

Aromatherapy and Pain

The Effect of Aromatherapy on the Incidence and Severity of Post Procedure Pain and Discomfort in Patients

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05910892
Enrollment
0
Registered
2023-06-20
Start date
2025-01-31
Completion date
2025-07-31
Last updated
2025-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

Intramuscular Stimulation Therapy, Trigger Point Injections, Aromatherapy

Brief summary

Effect of aromatherapy on pain and discomfort in patients who are receiving intramuscular stimulation therapy or trigger point injections for chronic pain.

Detailed description

The study will explore the effect of aromatherapy on pain and discomfort in patients who are receiving intramuscular stimulation therapy or trigger point injections for chronic pain. This will be a blinded study where patients will act as their own control over two treatment visits. On one visit patient will be exposed to either the aromatherapy or a placebo. On their second visit patients will be exposed to the other compound. The study will collect demographic data, pain intensity and affect, and catastrophizing information.

Interventions

DRUGAromatherapy packet

5 deep breaths from packet prior to treatment

DRUGPlacebo packet

5 deep breaths from packet prior to treatment

Sponsors

University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have received at least one (1) prior IMS or trigger point injection treatment with researcher * 18 years of age or older * English language speaker * has completed Pain Tracker (clinic standard of care) questionnaire prior to study visit * any analgesic medication taken must be consistent for both sessions

Exclusion criteria

* Non-English language speaker * Age \<18 * Allergy to essential oils * Asthmatic * Patient unable to self-administer aromatherapy

Design outcomes

Primary

MeasureTime frameDescription
Change in Acute PainImmediately after the ProcedureExamine the change in Acute Pain associated with two identical procedures involving muscle with either an aromatherapy intervention or control intervention. With each patient being their own control, patients will rate their acute pain immediately after the procedure on a 0-10 scale (0=No pain and 10=Pain as bad as you can imagine).

Secondary

MeasureTime frameDescription
Change in Overall ExperienceImmediately after the ProcedureExamine the change in Overall Experience of pain with two identical procedures involving muscle with either an aromatherapy intervention or control intervention. With each patient being their own control, patients will rate their overall experience of pain after the procedure on a 0-10 scale (0=No pain and 10=Pain as bad as you can imagine).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026